{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:40:50Z","timestamp":1770352850308,"version":"3.49.0"},"reference-count":67,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"36","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Society of Clinical Oncology Educational Book"],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:p> Primary mediastinal large B-cell lymphoma (PMLBCL) is recognized as a distinct disease entity. Treatment outcomes appear better than in other diffuse large B-cell lymphoma (DLBCL) types, partly because of their earlier stage at presentation and the younger age of most patients. If initial treatment fails, however, the results of salvage chemotherapy and myeloablative treatment are poor. The need to avoid relapses after initial therapy has led to controversy over the extent of front-line therapy, particularly whether consolidation radiotherapy to the mediastinum is always required and whether the 18-fluorodeoxyglucose (<jats:sup>18<\/jats:sup>F-FDG) uptake detected by PET-CT scan can be used to determine its requirements. Functional imaging using PET-CT generally allows distinguishing of residual mediastinal masses containing active lymphoma from those with only sclerotic material remaining. The International Extranodal Lymphoma Study Group (IELSG) conducted the prospective IELSG-26 study, which showed that a five-point visual scale can be used to define metabolic response after immunochemotherapy and that a cut point based on liver uptake discriminates effectively between high or low risk of failure, with 5-year progression-free survival (PFS) of 99% versus 68% and 5-year overall survival (OS) of 100% versus 83%. This study also showed that a baseline quantitative PET parameter, namely the total lesion glycolysis describing the metabolic tumor burden, can be a powerful predictor of PMLBCL outcomes and warrants further validation as a biomarker. The ongoing IELSG-37 randomized study addresses the need for consolidation mediastinal radiotherapy in patients in whom a complete metabolic response (CMR) can be seen on PET scans after standard immunochemotherapy. <\/jats:p>","DOI":"10.1200\/edbk_159037","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T17:46:40Z","timestamp":1540835200000},"page":"e368-e375","source":"Crossref","is-referenced-by-count":7,"title":["Functional Imaging Using 18-Fluorodeoxyglucose PET in the Management of Primary Mediastinal Large B-Cell Lymphoma: The Contributions of the International Extranodal Lymphoma Study Group"],"prefix":"10.1200","author":[{"given":"Franco","family":"Cavalli","sequence":"first","affiliation":[{"name":"From the Oncology Institute of Southern Switzerland, Lymphoma Unit\u2013Ospedale San Giovanni, Bellinzona, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Ceriani","sequence":"additional","affiliation":[{"name":"From the Oncology Institute of Southern Switzerland, Lymphoma Unit\u2013Ospedale San Giovanni, Bellinzona, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Zucca","sequence":"additional","affiliation":[{"name":"From the Oncology Institute of Southern Switzerland, Lymphoma Unit\u2013Ospedale San Giovanni, Bellinzona, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"bibr1-EDBK_159037","first-page":"250","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Gaulard P","year":"2008"},{"key":"bibr2-EDBK_159037","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1182\/asheducation-2008.1.349","volume":"2008","author":"Johnson PW","year":"2008","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"bibr3-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-1841"},{"key":"bibr4-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031074"},{"key":"bibr5-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-326538"},{"key":"bibr6-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.6.1855"},{"key":"bibr7-EDBK_159037","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1586\/17474086.2015.994604","volume":"8","author":"Martelli M","year":"2015","journal-title":"Expert Rev Hematol"},{"key":"bibr8-EDBK_159037","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9440(10)63815-1","volume":"162","author":"Pileri SA","year":"2003","journal-title":"Am J Pathol"},{"key":"bibr9-EDBK_159037","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1080\/10428190310001623810","volume":"44","author":"Pileri SA","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"bibr10-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4901"},{"key":"bibr11-EDBK_159037","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1182\/blood-2009-03-209759","volume":"114","author":"Ritz O","year":"2009","journal-title":"Blood"},{"key":"bibr12-EDBK_159037","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1158\/1078-0432.CCR-13-3007","volume":"20","author":"Hao Y","year":"2014","journal-title":"Clin Cancer Res"},{"key":"bibr13-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20420"},{"key":"bibr14-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.4.1571.bloodjournal8741571"},{"key":"bibr15-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3701"},{"issue":"3","key":"bibr16-EDBK_159037","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/gcc.22328","volume":"55","author":"Mareschal S","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"bibr18-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj030"},{"key":"bibr19-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq418"},{"key":"bibr20-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1080\/10428190802108870"},{"key":"bibr21-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199607000-00012"},{"key":"bibr22-EDBK_159037","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/10428199909169618","volume":"35","author":"Bieri S","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"bibr23-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.12.2306"},{"key":"bibr24-EDBK_159037","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1182\/blood.V94.10.3289.422k32_3289_3293","volume":"94","author":"Zinzani PL","year":"1999","journal-title":"Blood"},{"key":"bibr25-EDBK_159037","first-page":"187","volume":"86","author":"Zinzani PL","year":"2001","journal-title":"Haematologica"},{"key":"bibr26-EDBK_159037","first-page":"1258","volume":"87","author":"Zinzani PL","year":"2002","journal-title":"Haematologica"},{"key":"bibr27-EDBK_159037","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.bjc.6601460","volume":"90","author":"Todeschini G","year":"2004","journal-title":"Br J Cancer"},{"key":"bibr28-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05661.x"},{"key":"bibr29-EDBK_159037","doi-asserted-by":"crossref","unstructured":"Dunleavy K, Pittaluga S, Janik J, et al. Primary mediastinal large B-cell lymphoma (PMBL) outcome is significantly improved by the addition of rituximab to dose adjusted (DA)-EPOCH and overcomes the need for radiation. Blood. 2005;106:929.","DOI":"10.1182\/blood.V106.11.929.929"},{"key":"bibr30-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70002-0"},{"key":"bibr31-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-276246"},{"key":"bibr32-EDBK_159037","doi-asserted-by":"crossref","unstructured":"Trneny M, Osterborg A, Pettengel R, et al. The addition of rituximab eliminates the negative prognostic impact of PMLBCL compared to DLBCL in young patients with CD20-positive aggressive lymphomas receiving a CHOP-like chemotherapy: results of a subgroup analysis of the Mabthera International Trial Group (MInT) study. Blood. 2008;112:839.","DOI":"10.1182\/blood.V112.11.839.839"},{"key":"bibr33-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2009.n.074"},{"key":"bibr35-EDBK_159037","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3324\/haematol.12742","volume":"93","author":"Zinzani PL","year":"2008","journal-title":"Haematologica"},{"key":"bibr36-EDBK_159037","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ijrobp.2006.12.048","volume":"68","author":"Mazzarotto R","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bibr37-EDBK_159037","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.ijrobp.2008.02.036","volume":"72","author":"De Sanctis V","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bibr38-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-4296(96)80018-X"},{"key":"bibr39-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.3.487"},{"key":"bibr41-EDBK_159037","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.ijrobp.2009.07.011","volume":"77","author":"Yoon M","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bibr42-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.55.2.117"},{"key":"bibr43-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1002\/hon.743"},{"key":"bibr44-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.4444"},{"key":"bibr45-EDBK_159037","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.radonc.2006.10.015","volume":"82","author":"Nieder C","year":"2007","journal-title":"Radiother Oncol"},{"key":"bibr46-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214561"},{"key":"bibr47-EDBK_159037","doi-asserted-by":"crossref","unstructured":"Savage KJ, Yenson PR, Shenkier T, et al. The outcome of primary mediastinal large B-cell lymphoma (PMLBCL) in the R-CHOP treatment era. Blood. 2012;120:303.","DOI":"10.1182\/blood.V120.21.303.303"},{"key":"bibr48-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.5229"},{"key":"bibr49-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"bibr50-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13441"},{"key":"bibr51-EDBK_159037","first-page":"CD010533","volume":"1","author":"Sickinger MT","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr52-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.6525"},{"key":"bibr53-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.103218"},{"key":"bibr54-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.9846"},{"key":"bibr55-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.3109\/10428190009113384"},{"key":"bibr56-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.2.414"},{"key":"bibr57-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602040"},{"key":"bibr58-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-07-653386"},{"key":"bibr59-EDBK_159037","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/hon.2212","volume":"33","author":"Johnson PWM","year":"2015","journal-title":"Hematol Oncol"},{"key":"bibr60-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10798"},{"key":"bibr61-EDBK_159037","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.ijrobp.2006.07.1365","volume":"66","author":"Kahn ST","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bibr62-EDBK_159037","doi-asserted-by":"crossref","unstructured":"Moskowitz C, Hamlin PA Jr, Maragulia J, et al. Sequential dose-dense RCHOP followed by ICE consolidation (MSKCC protocol 01-142) without radiotherapy for patients with primary mediastinal large B cell lymphoma. Blood. 2010;116:420.","DOI":"10.1182\/blood.V116.21.420.420"},{"key":"bibr63-EDBK_159037","doi-asserted-by":"crossref","unstructured":"Sehn LH, Hoskins P, Klasa R, et al. FDG-PET scan guided consolidative radiation therapy optimizes outcome In patients with advanced-stage diffuse large B-cell lymphoma (DLBCL) with residual abnormalities on CT scan following R-CHOP. Blood. 2010;116:854.","DOI":"10.1182\/blood.V116.21.854.854"},{"key":"bibr64-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.2403"},{"key":"bibr65-EDBK_159037","author":"Zinzani PL","year":"2015","journal-title":"Hematol Oncol"},{"key":"bibr66-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.7524"},{"key":"bibr67-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1080\/10428190903040048"},{"key":"bibr69-EDBK_159037","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-616474"},{"key":"bibr70-EDBK_159037","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40336-015-0132-0","volume":"3","author":"Meignan M","year":"2015","journal-title":"Clin Transl Imaging"},{"key":"bibr71-EDBK_159037","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00259-014-2973-6","volume":"42","author":"Meignan M","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["American Society of Clinical Oncology Educational Book"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/EDBK_159037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T09:18:38Z","timestamp":1653815918000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/EDBK_159037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":67,"aliases":["10.14694\/edbk_159037"],"journal-issue":{"issue":"36","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1200\/EDBK_159037"],"URL":"https:\/\/doi.org\/10.1200\/edbk_159037","relation":{},"ISSN":["1548-8748","1548-8756"],"issn-type":[{"value":"1548-8748","type":"print"},{"value":"1548-8756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}